BioForce Nanosciences Holdings, Inc. (BFNH)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
BioForce Nanosciences Holdings, Inc. (BFNH) with AI Score 42/100 (Weak). BioForce Nanosciences Holdings, Inc. operates in the consumer defensive sector, focusing on natural nutritional supplements. Market cap: 0, Sector: Consumer defensive.
Last analyzed: Mar 15, 2026BioForce Nanosciences Holdings, Inc. (BFNH) Consumer Business Overview
BioForce Nanosciences Holdings, Inc. develops and distributes natural vitamins, minerals, and nutritional supplements, targeting a broad age demographic. The company differentiates itself through private label offerings and the BioForce Eclipse brand, navigating a competitive packaged foods market focused on health and wellness.
Investment Thesis
BioForce Nanosciences Holdings, Inc. presents a speculative investment opportunity within the consumer defensive sector. The company's focus on natural supplements aligns with growing health and wellness trends, potentially driving revenue growth. However, the company's small market capitalization of $0.02 billion and negative P/E ratio of -12.67 indicate significant financial challenges. Key value drivers include expanding private label partnerships and increasing online sales. Upcoming catalysts include potential new product launches and expansion into new retail channels. Potential risks include intense competition, limited financial resources, and the inherent volatility of OTC-traded stocks. Investors should carefully consider these factors before investing.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.02 billion indicates a micro-cap company with high growth potential but also high risk.
- Negative P/E ratio of -12.67 reflects current unprofitability, requiring careful monitoring of future earnings potential.
- Beta of -0.77 suggests a potential inverse correlation with the market, which could offer downside protection during market downturns.
- Focus on natural vitamins and supplements aligns with growing consumer demand for health and wellness products.
- The company's reliance on private label products and distributors presents both opportunities and risks in terms of revenue diversification and margin control.
Competitors & Peers
Strengths
- Focus on natural and healthy ingredients.
- Private label manufacturing capabilities.
- Established distribution network.
- Brand recognition through BioForce Eclipse.
Weaknesses
- Small market capitalization.
- Limited financial resources.
- Negative P/E ratio indicating unprofitability.
- Reliance on third-party distributors.
Catalysts
- Upcoming: Potential new product launches in the natural supplement category, targeting specific health needs.
- Ongoing: Expansion of private label partnerships with retailers and distributors.
- Ongoing: Increased online sales through targeted marketing campaigns and e-commerce optimization.
Risks
- Potential: Intense competition from larger, more established players in the supplement industry.
- Potential: Changing consumer preferences and trends in the health and wellness market.
- Ongoing: Limited financial resources and potential difficulty in raising capital.
- Ongoing: Regulatory changes and compliance requirements affecting the supplement industry.
- Potential: Economic downturn affecting consumer spending on non-essential products.
Growth Opportunities
- Expansion of Private Label Partnerships: BioForce Nanosciences can increase revenue by securing additional private label contracts with retailers and distributors. The private label market is projected to reach $250 billion by 2028, offering significant growth potential. Success depends on competitive pricing, product quality, and reliable supply chain management. Timeline: Ongoing.
- Increased Online Sales: The company can leverage the growing e-commerce market to expand its reach and increase sales. The online supplement market is expected to grow by 10% annually, reaching $40 billion by 2027. Investing in a user-friendly website, targeted marketing campaigns, and efficient order fulfillment are crucial. Timeline: Ongoing.
- New Product Development: Introducing innovative and specialized nutritional supplements can attract new customers and increase market share. The market for personalized nutrition is expanding rapidly, driven by advancements in genomics and data analytics. Focusing on niche markets, such as sports nutrition or senior health, can provide a competitive advantage. Timeline: Upcoming, within 12-18 months.
- Strategic Acquisitions: Acquiring smaller supplement companies or specialized ingredient suppliers can expand product offerings and improve supply chain control. The fragmented supplement industry presents numerous acquisition opportunities. Careful due diligence and integration planning are essential for success. Timeline: Potential, within 24-36 months.
- Geographic Expansion: Expanding into new geographic markets, particularly in Asia and Europe, can significantly increase revenue. The global supplement market is expected to reach $280 billion by 2028, with strong growth in emerging markets. Adapting product formulations to local preferences and navigating regulatory requirements are key considerations. Timeline: Potential, within 36-48 months.
Opportunities
- Expansion of private label partnerships.
- Increased online sales through e-commerce.
- New product development and innovation.
- Strategic acquisitions of smaller companies.
Threats
- Intense competition in the supplement industry.
- Changing consumer preferences and trends.
- Regulatory changes and compliance requirements.
- Economic downturn affecting consumer spending.
Competitive Advantages
- Brand recognition through the BioForce Eclipse brand.
- Private label manufacturing capabilities.
- Established distribution network with retailers and online channels.
About BFNH
BioForce Nanosciences Holdings, Inc., based in Virginia Beach, Virginia, is a provider of natural vitamins, minerals, and nutritional supplements. The company focuses on developing and distributing products aimed at individuals across various age ranges, emphasizing health and wellness. BioForce Nanosciences operates primarily through private label partnerships, collaborating with distributors and manufacturing providers to create custom formulations. Its own brand, BioForce Eclipse, is sold through a variety of channels, including retailers, sporting goods stores, supermarkets, mass merchandisers, and online platforms, as well as through telemarketing efforts. The company's business model centers around offering both branded and private label nutritional supplements. This allows it to cater to a diverse range of customers, from large retail chains seeking to offer their own branded products to individual consumers looking for specific health and wellness solutions. The company's focus on natural ingredients aligns with growing consumer demand for healthier food and supplement options. However, the company's small size and limited resources present challenges in competing with larger, more established players in the packaged foods and supplement industry. The company's success depends on its ability to effectively manage its supply chain, maintain product quality, and adapt to changing consumer preferences in the dynamic health and wellness market.
What They Do
- Develops natural vitamins and minerals.
- Offers nutritional supplements for various age ranges.
- Provides private label product manufacturing.
- Distributes products under the BioForce Eclipse brand.
- Sells to retailers, sporting goods stores, and supermarkets.
- Markets products online and through telemarketing.
Business Model
- Develops and manufactures natural vitamins and supplements.
- Offers private label manufacturing services to distributors and retailers.
- Sells branded products through retail channels and online platforms.
Industry Context
BioForce Nanosciences Holdings, Inc. operates within the competitive packaged foods industry, specifically targeting the nutritional supplements market. This market is characterized by increasing consumer awareness of health and wellness, driving demand for natural and organic products. The industry includes major players like CFOO, DTEAF, ELAMF, HNFSA, and INBP, as well as numerous smaller companies. BioForce Nanosciences competes by offering both branded and private label products, focusing on quality and natural ingredients. The company's success depends on its ability to differentiate itself in a crowded market and effectively reach its target customers.
Key Customers
- Retailers seeking private label nutritional supplements.
- Sporting goods stores and supermarkets.
- Individual consumers looking for natural vitamins and minerals.
Financials
Chart & Info
BioForce Nanosciences Holdings, Inc. (BFNH) stock price: Price data unavailable
Latest News
No recent news available for BFNH.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BFNH.
Price Targets
Wall Street price target analysis for BFNH.
MoonshotScore
What does this score mean?
The MoonshotScore rates BFNH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Steven Gagnon
CEO
Steven Gagnon serves as the CEO of BioForce Nanosciences Holdings, Inc. His leadership is focused on guiding the company's strategic direction and overseeing its operations in the nutritional supplement market. With a small team of three employees, Gagnon's role encompasses a wide range of responsibilities, from product development and marketing to sales and distribution. His experience in the consumer goods sector is crucial for navigating the competitive landscape and driving growth.
Track Record: Under Steven Gagnon's leadership, BioForce Nanosciences has focused on expanding its private label partnerships and increasing its online presence. Key milestones include the development of new product formulations and the establishment of relationships with key retailers and distributors. The company's success depends on Gagnon's ability to effectively manage resources and adapt to changing market conditions.
BFNH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that BioForce Nanosciences Holdings, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports, increasing the risk for investors due to lack of transparency. Investing in OTC Other stocks requires a higher level of due diligence and awareness of potential risks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing due to lack of transparency.
- Low trading volume can lead to price volatility and difficulty in buying or selling shares.
- OTC Other stocks may be subject to less regulatory oversight, increasing the potential for fraud or manipulation.
- The company may not meet the minimum financial standards of higher-tier exchanges, indicating potential financial instability.
- Limited analyst coverage and public information can make it difficult to assess the company's true value and prospects.
- Verify the company's registration and legal standing with the relevant regulatory authorities.
- Obtain and review any available financial statements, including balance sheets, income statements, and cash flow statements.
- Assess the company's management team and their experience in the industry.
- Research the company's products or services and their competitive positioning in the market.
- Evaluate the company's business model and its ability to generate sustainable revenue and profits.
- Determine the level of trading volume and liquidity for the stock.
- Understand the risks associated with investing in OTC Other stocks and the potential for loss.
- The company has an established website and online presence.
- The company has been in operation for several years.
- The company has a registered business address and contact information.
- The company offers tangible products or services.
- The company has a management team in place.
BFNH Consumer Defensive Stock FAQ
What does BioForce Nanosciences Holdings, Inc. do?
BioForce Nanosciences Holdings, Inc. is a consumer defensive company focused on the development, manufacturing, and distribution of natural vitamins, minerals, and nutritional supplements. It operates through private label partnerships and its own BioForce Eclipse brand, targeting a broad range of consumers seeking health and wellness products. The company sells its products through retailers, sporting goods stores, supermarkets, online platforms, and telemarketing channels, aiming to provide accessible and high-quality nutritional solutions.
What do analysts say about BFNH stock?
There is currently no available analyst coverage for BFNH stock due to its small market capitalization and OTC listing. Key valuation metrics, such as P/E ratio (-12.67), reflect current unprofitability. Growth considerations include the company's ability to expand its private label partnerships and increase online sales. Investors should conduct their own thorough research and consider the risks associated with investing in OTC-traded stocks before making any investment decisions.
What are the main risks for BFNH?
The main risks for BioForce Nanosciences Holdings, Inc. include intense competition in the supplement industry, limited financial resources, and the inherent volatility of OTC-traded stocks. The company's small market capitalization and negative P/E ratio indicate significant financial challenges. Additionally, changing consumer preferences and regulatory requirements could impact the company's ability to maintain market share and profitability. Investors should carefully consider these risks before investing.
How does BioForce Nanosciences Holdings, Inc. adapt to changing consumer preferences?
BioForce Nanosciences Holdings, Inc. adapts to changing consumer preferences by monitoring market trends and investing in new product development. The company focuses on natural and healthy ingredients, aligning with growing consumer demand for clean label products. Additionally, the company leverages its private label capabilities to offer customized formulations that meet the specific needs of its retail partners. The company also utilizes online and telemarketing channels to gather consumer feedback and adjust its product offerings accordingly.
What is BioForce Nanosciences Holdings, Inc.'s geographic revenue mix?
Information regarding BioForce Nanosciences Holdings, Inc.'s geographic revenue mix is not publicly available. Given the company's small size and OTC listing, detailed financial disclosures are limited. Investors may want to evaluate this lack of transparency as a risk factor when evaluating the company's investment potential. Further investigation may be required to determine the company's geographic reach and international growth prospects.
What are the key factors to evaluate for BFNH?
BioForce Nanosciences Holdings, Inc. (BFNH) currently holds an AI score of 42/100, indicating low score. Key strength: Focus on natural and healthy ingredients.. Primary risk to monitor: Potential: Intense competition from larger, more established players in the supplement industry.. This is not financial advice.
How frequently does BFNH data refresh on this page?
BFNH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven BFNH's recent stock price performance?
Recent price movement in BioForce Nanosciences Holdings, Inc. (BFNH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on natural and healthy ingredients.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC listing and small market capitalization.
- Financial data may not be fully up-to-date or audited.